ArticleFrontiers in cell and developmental biology2021

Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents.

Chung-Pu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.